–
Vol. 38, №
1.
–
P. 1-8.
18
Zaffanello M., Franchini M., Fanos V. Is serum Cystatin-C a suitable
marker of renal function in children? // Ann. Clin. Lab. Sci. – 2007.
–
Vol. 37, № 3. –
P. 233-40.
19
Новикова М.С., Кутырина И.М., Шилова Е.М. Современные методы
определения скорости клубочковой фильтрации у лиц с нормальной и
избыточной массой тела // Терапевтический архив. – 2010. – № 3. – С. 67-71.
20
Аниконова Л.И.,
Радченко
В.Г.,
Ряснянский
В.Ю
.
и др.
Цистатин С
как ранний биомаркер контраст-индуцированного острого почечного
повреждения // Нефрология. – 2012. – Т. 16, № 2
.
– С. 84-89.
21
Каюков И.Г., Смирнов А.В., Эмануэль В.Л. Цистатин в современной
медицине / // Нефрология. – 2012. – Т. 16, № 1. – С. 22-39.
22
Bacchetta J., Cochat P., Rognant N., Ranchin B., Hadj-Aissa A.,
Dubourg L. Which creatinine and cystatin C equations can be reliably used in
children? // Clin. J. Am. Soc. Nephrol. – 2011. – Vol. 6, № 3. – P. 552-60.
23
Смирнов А.В., Каюков И.Г., Есаян A.M. и др. Проблема оценки
скорости клубочковой фильтрации в современной нефрологии: новый
индикатор цистатин С // Нефрология. – 2005. – Т. 9, №3. – С. 16-27.
24
Andersen
T.B.,
Erlandsen
E.J.,
Frokiaer
J.,
Eskild
-
Jensen
A.,
Brochner
-
Mortensen J.B
.
Comparison of within- and between-subject variation of
serum cystatin С and serum creatinine in children aged 2-13 years // Scand. J. Clin.
Lab. Invest. – 2010. – Vol. 70, №1. – P. 54-59.
25
Herget-Rosenthal S., Feldkamp T., Volbracht L., Kribben A.
Measurement of urinary cystatin C by particle-enhanced nephelometric
immunoassay: precision, interferences, stability and reference range. //Ann. Clin.
Biochem. – 2004. – Vol. 41. – P. 111-118.
26
Manetti L., Pardini E., Genovesi M. et al. Thyroid function differently
affects serum cystatin C and creatinine concentrations // J. Endocrinol. Invest. –
2005. – Vol. 28. – P. 346-349.
27
Coca S.G., Yalavarthy R., Concato J. et al. Biomarkers for the diagnosis
and risk stratification of acute kidney injury: a systematic review // Kidney Int. –
2007. – Vol. 19. – 19 р.
28
Global Burden of Disease Study 2013 Collaborators Global, regional, and
national incidence, prevalence, and years lived with disability for 301 acute and
chronic diseases and injuries in 188 countries, 1990-2013. a systematic analysis for
the Global Burden of Disease Study 2013 // Lancet. –2015. – Vol. 386. – P. 743–800.
29
Walker C.L., Rudan I., Liu L. et al. Global burden of childhood
pneumonia and diarrhea // Lancet. – 2013. – Vol. 381. – P. 1405–1416.
30
Смирнова Н.Н., Белозерцева В.Н. Вторичные нефропатии при
71
патологии Органов пищеварения у детей // Terra medica. – 2016. – №3. – С. 8-10.
31
Воротынцева Н.В. Гемолитико-уремический синдром у детей //
Эпидемиология и инфекционные болезни. – 2003. – № 6. – С. 39-42.
32
Kellum J.A. Acute kidney injury // Crit. Care. Med. – 2008. – Vol. 36. –
Р. 141-145.
33
Бема М.B. Взаимосвязь патологии мочевой системы и органов
пищеварения у детей // Бюлл ВСНЦ СО РАМН. – 2012. – №2 (84). – С. 17-19.
34
Coresh J., Balk E., Kausz A.T. et al. National Kidney Foundation.
National Kidney Foundation Practice Guidelines for Chronic Kidney Disease:
Evaluation, Classification, and Stratification // Ann. Internal. med. – 2003. – Vol. 139
(2). – P. 137-147.
35
Vaziri N.D., Yuan.J., Nazertehrani S. et al. Chronic Kidney Disease
Causes disruption of gastric and Small Intestinal Epithelial Tight Junction // Amer. J.
Nephrol. – 2013. – Vol. 38. – P. 99–103.
36
Yilgwan C.S., Okolo S.N. Prevalence of diarrhea disease and risk factors
in Jos University Teaching Hospital // Ann. Afr. Med. – 2012. – Vol. 11. – № 4. – P.
217-221.
37
Bhutta Z.A., Das J.K., Walker N. et al. Interventions to address
deathsfrom childhood pneumonia and diarrhoea equitably: what works and at what co
st? // Lancet. – 2013. – Vol. 381, № 9875. – P. 29–1417.
38
Dekate P., Jayashree M., Singhi S.C. Management of acute diarrhea in
emergency room // Indian J. Pediatr. – 2013. – Vol. 80, № 3. – P. 46-235.
39
Lamberti L.M., Fischer C.L., Walker R.E. Black Systematic review of
diarrhea duration and severity in children and adults in low- and middle-income
countries // BMC Public Health. – 2012. – № 12. – 276 p.
40
ВОЗ. Причины смерти 2008 сводные таблицы. www.who.int
.
41
Alkizim F., Matheka D., Muriithi A. Childhood diarrhoea: failing
conventional measures, what next ?// Pan. Afr. Med. J. – 2011. – № 8. – 47 p.
42
Халиуллина С.В., Анохин В.А. Острые инфекционные диареи у
детей. Современные представления // Lambert Academic Publishing. – 2012. – 68
c.
43
Kuşkonmaz B., Yurdakök K., Yalcin S.S., Özmert E. Comparison of
acute bloody and watery diarrhea: a case-control study // Turk. J. Pediatr. – 2009. –
Vol. 51, № 2. – P. 40-133.
44
Webb A., Starr М. Acute gastroenteritis in children // Aust. Fam.
Physician. – 2005. – Vol. 34, № 4. – P. 31-227.
45
Steiner M.J., De Walt D.A., Byerley J.S. This child is dehydrated? //
JAMA. – 2004. – Vol. 291, № 22. – P. 54-2746.
46
Goldman R.D., Friedman J.N., Parkin Р.С. Validation of clinical
dehydration scale for children with acute gastroenteritis // Рediatrics. – 2008. – Vol.
122, № 3. – P. 9-545.
47
Treatment of diarrhea. A manual for physicians and other senior health
workers. WHO. www.euro.who.int. 2006.
48
Acute diarrhea in adults and children: a global perspective. WGO.
72
www.worldgastroenterology.org. 02.2012.
49
Evidence-based care guideline for prevention and management of acute
gastroenteritis (AGE) in children aged 2 months to 18 years. NGC:008846.
www.guideline.gov. 11.1999.
50
Guerrant R.L., Van Gilder T., Steiner T.S. et al. Practice guidelines for
the management of infectious diarrhea // Clin. Infect. Dis. – 2001. – Vol. 32, № 3. –
P. 51-331.
51
Учайкин В.Ф., Нисевич Н.И., Шамшева О.В. Инфекционные болезни
и вакцинопрофилактика у детей. – М.: ГЭОТАР-Медиа, 2007. – 687 с.
52
Республиканский центр развития здравоохранения. Клинические
протоколы. 2015. http://www.rcrz.kz/.
53
Жидков Ю.Б., Колотилов Л.В. Инфузионно-трансфузионная терапия
при инфекционных болезнях у детей и взрослых. – М.: МЕДпресс-информ,
2005. – 302 с.
54
Choong K., Arora S., Cheng J. et al. Hypotonic versus isotonic
maintenance fluids after surgery in children: A randomized controlled trial //
Pediatrics. – 2011. – Vol. 128, № 5. – P. 857-866.
55
Hasegawa H., Okubo S., Ikezumi Y., et al.
Hyponatremia due to an excess
of arginine vasopressin is common in children with febrile disease // Pediatr
Nephrol. – 2009. – Vol. 24, № 3. – P. 507-511.
56
Don М., Valerio G., Korppi M., Canciani M. Hyponatremia in pediatric
community-acquired pneumonia // Pediatr Nephrol. – 2008. – Vol. 23, № 12. – P.
2247-2253.
57
Don M. Hyponatremia in radiologically confirmed pediatric community-
acquired pneumonia // Pediatr. Emerg. Care. – 2014. – Vol. 30, № 1. – 76 p.
58
Халиуллина С.В., Анохин В.А., Николаева И.В., Валиахметова Л.Х.
Особенности острых кишечных инфекций, протекающих с синдромом
обезвоживания // Практическая медицина. – 2013. – Т. 75, № 6. – С. 133-140.
59
Forman S. The epidemiology of hypernatraemia in hospitalised children
in Lothian: a 10-year study showing differences between dehydration,
osmoregulatory dysfunction and salt poisoning // Arch. Dis. Child. – 2012. – Vol. 97,
№ 6. – P. 502-507.
60
Bihari S. Sodium administration in critically ill patients in Australia and
New Zealand: a multicentre point prevalence study // Crit. Care. Resusc. – 2013. –
Vol. 15, № 4. – P. 294-300.
61
Халиуллина С.В., Анохин В.А., Николаева И.В., Валиахметова Л.Х.
Особенности острых кишечных инфекций, протекающих с синдромом
обезвоживания // Практическая медицина. – 2013. – Т. 75, № 6. – С. 133-140.
62
Boyd J.H., Forbes J., Nakada T.A. et.al. Fluid resuscitation in septic
shock: a positive fluid balance and elevated central venous pressure are associated
with increased mortality // Crit. Care. Med. – 2011. – Vol. 39, №2. – P. 259–265.
63
Rabb H., Wang Z., Nemoto T., Hotchkiss. J, Yokota. N., Soleimani М.
Acute renal failure leads to dysregulation of lung salt and water channels // Kidney
Int. – 2003. – Vol. 63, №2. – P. 600–606.
73
64
Grams M.E , Estrella MM, Coresh .J, Brower R.G., Liu K.D. Fluid
balance, diuretic use, and mortality in acute kidney injury // Clin. J. Am. Soc.
Nephrol. – 2011. – Vol. 6, №5. – P. 966–973.
65
Binder H.J., Brown I., Ramakrishna B.S., Young G.P. Oral Rehydration
Therapy in the Second Decade of the Twenty-first Century // Curr. Gastroenterol.
Rep. – 2014. – Vol. 16, № 3. – 376 р.
66
Guarino А. et al. European Society for Paediatric Gastroenterology,
Hepatology аnd Nutrition/European Society for PaediatricInfectious Diseases
evidence-based guidelines for the management of acute gastroenteritis in children in
Europe // J. Pediatr. Gastroenterol. Nutr. – 2008. – Vol. 46, № 2. – P. 81-122.
67
Гулямов Н.Г., Ахмедова Х.Ю., Далимов Т.К., Имамова И.А.,
Юлдашева Ф.З. Диагностическое значение показателей антигенсвязывающих
лимфоцитов оценке поражения органов при инфекциoнной и неинфекционной
патологии // Инфекция, иммунитет и фармакология. – 2005. – №3. – С.115-118.
68
Смирнова Н.Н., Белозерцева В.Н. Вторичные нефропатии при
патологии органов пищеварения у детей // Terra medica. – 2016. – № 3. – С. 8-10.
69
Смирнов А.В., Каюков И.Г., Дегтерева О.А.
и др.
Проблемы
диагностики и стратификации тяжести острого повреждения почек //
Нефрология. – 2009. – Т. 13, № 3. – С. 9-18.
70
Bellomo R., Ronco C., Kellum J.A., Mehta R.L., Palevsky P. Acute renal
failure - definition, outcome measures, animal models, fluid therapy and information
technology needs: the Second International Consensus Conference of the Acute
Dialysis Quality Initiative (ADQI) Group // Crit. Care. – 2004. – Vol. 8, №4. – P.
204-212.
71
Кишкун А.А. Руководство по лабораторным методам диагностики. –
М.: ГЭОТАР-Медиа, 2007. – 800 с.
72
Devarjan P, Emerging biomarkers of acute kidney injury // Contrib.
Nephrol. – 2007. – Vol. 156. – P. 203–212.
73
Devarjan P. The strong silent type: the distal tubule to the rescue // Crit.
Care Med. – 2009. – Vol. 37. – P. 2129–2130.
74
Uchino S., Bellomo R., Bagshaw S.M., Goldsmith D. Transient azotaemia
is associated with a high risk of death in hospitalized patients // Nephrol. Dial.
Transplant. – 2010. – Vol. 25. – P. 1833–1839.
75
Fang Y., Ding X., Zhong Y., Zou J., Teng J., Tang Y. et al. Acute kidney
injury in a Chinese hospitalized population // Blood Purif. – 2010. – Vol. 30, №2. –
Р. 120–126.
76
Riley S., Diro E., Batchelor P., Abebe A., Amsalu A., Tadesse Y. et al.
Renal impairment among acute hospital admissions in a rural Ethiopian hospital //
Nephrology (Carlton). – 2013 – Vol. 18, № 2. – Р. 92–96.
77
Сукало А. Острая почечная недостаточность у новорожденных //
Педиатрия. – 2008. – №39. – С. 873-876.
78
Andreoli S. P. Acute kidney injury in children // Pediatr. Nephrol. –
2009. – №24. – P. 256-263.
79
Guignard J.P., Drukker A. Clinical neonatal nephrology. In: Barrat TM,
74
Avner ED, Harmon WE, 9 eds. // Pediatric Nephrology. Philadelphia: Lippincott
Williams&Wilkins. – 2009. – Р. 1123–1129.
80
Plotz F.B., Bouma A.B., van Wijk J.A., Kneyber M.C., Bokenkamp A.
Pediatric acute kidney injury in the ICU: an independent evaluation of pRIFLE
criteria // Intensive Care Med. – 2008. – Vol. 9. – P. 1713–1717.
81
Andreoli S.P. Acute renal failure in the newborn // Semin. Perinatol. –
2004. – Vol. 28. – P. 112-123.
82
Чемоданова М.А., Савенкова Н.Д. Особенности повреждения почек
при острых отравлениях у детей // Нефрология. – 2012. – №1. – С. 66-73.
83
Лойманн Э., Цыгин А.Н., Саркисян А.А. Детская нефрология. – М.,
2010. – 400 с.
84
Папаян А.В., Стяжкина И.С. Неонатальная нефрология. – М., 2009. –
132 с.
85
Heung M., Chawla L.S. Predicting progression to chronic kidney disease
after recovery from acute kidney injury // Curr. Opin. Nephrol. Hypertens. – 2012. –
Vol. 21, №6. – P. 628–634.
86
Bellomo R., Ronco C., Kellum J.A. et al. Acute renal failure – definition,
outcome measures, animal models, fluid therapy and information technology needs:
the Second International Consensus Conference of the Acute Dialysis Quality
Initiative (ADQI) Group // Crit. Care. – 2004. – Vol. 8, № 4. – Р. 204-212.
87
Lewington A.J., Sayed A. Acute kidney injury: how do we define it? //
Ann. Clin. Biochem. – 2010. – Vol. 47. – P. 4-7.
88
Папаян А.В., Савенкова Н.Д. // Клиническая нефрология детского
возраста. – М., 2010. – 712 с.
89
Mehta R.I., Kellum J.A, Shah S.V. et al. Acute Kidney Injury Network:
report of an initiative to improve outcomes in acute kidney injury // Crit. Care. –
2007. – Vol. 11. – 31 р.
90
Bagshaw S.M., George C., Bellomo R. A comparison of the RIFLE and
AKIN criteria for acute kidney injury in critically ill patients // Nephrol. Dial.
Transplant. – 2008. – Vol. 23. – Р. 1569–1574.
91
Ricci Z., Cruz D., Ronco C. The RIFLE criteria and mortality in acute
kidney injury: a systematic review // Kidney Int. – 2008. – Vol. 73, № 5. – P. 538-
546.
92
Akcan-Arikan., Zappitelli M., Loftis L.L. et al. Modified RIFLE criteria
in critically ill children with acute kidney injury // Kidney Int. – 2007. – № 71. – P.
1028-1035.
93
Slater M.B., Anand V., Uleryk E.M. et al. A systematic review of RIFLE
criteria in children, and its application and association with measures of mortality and
morbidity // Kidney Int. – 2012. – № 81. – P.791-798.
94
Hoste E.A, Kellum J.A. Acute kidney injury: epidemiology and diagnostic
criteria // Curr. Opin. Crit. Care. – 2006. – Vol. 12, №6. – P. 531-537.
95
D’Amico G., Bazzi C. Urinary protein and enzyme secretion as markers
of tubular damage // Curr. Opin. Nephrol. Hypertens. – 2003. – № 12. – Р. 639-643.
96
Esson M.L., Schrier R.W. Diagnosis and Treatment of Acute Tubular
75
Necrosis // Ann. Int. Med. – 2002. – Vol. 137, №9. – Р. 744-752.
97
Ferrera N. Vascular tndothelial growth factor // Arterioscler. Thromb.
Vasc. Biol. – 2009. – № 29. – Р. 789-791.
98
Edelstein C.L. Biomarkers of acute kidney injury // Adv. Chronic. Kidney
Dis. – 2008. –Vol. 15, №3. – Р. 222-234.
99
Han W.K., Waikar S.S., Johnson A. et al. Urinary biomarkers in the early
diagnosis of acute kidney injury // Kidney Int. – 2008. – №73. – Р. 863-869.
100
Мухин Н.А. Снижение скорости клубочковой фильтрации
общепопуляционный маркер неблагоприятного прогноза // Терапевтический
архив. – 2007. – № 6. – С. 5-10.
101
Сагинова Е., Галлямов М. Определение скорости клубочковой
фильтрации необходимый скрининговый метод обследования терапевтических
больных // Врач. – 2007. – № 6. – С. 35-37.
102
Томилина Н.А., Бигбов Б.Т. Эпидемиология хронической почечной
недостаточности и новые подходы к классификации и оценке тяжести
хронических прогрессирующих заболевания почек // Терапевтический архив. –
2005. – № 6. – С. 87-92.
103
Coca S.G., Parikh C.R. Urinary biomarkers for acute kidney injury:
perspectives on translation // Clin. J. Am. Soc. Nephrol. – 2008. – Vol. 3, №2. – P.
481-490.
104
Bellomo R., Kellum J.A., Ronco С. Defining acute renal failure:
Physiological principles // Intensive Care Med. – 2004. – Vol. 30. – P. 33- 37.
105
Schwartz G.J., Haycock G.B., Edelmann C.M., Spitzer A. A simple
estimate of glomerular filtration rate in children derived from body length and plasma
creatinine // Pediatrics. – 1976. – Vol. 58. – P. 259-263.
106
Schwartz G.J., Munoz A., Schneider M.F., et al. New equations to
estimate GFR in children with CKD // J. Am. Soc. Nephrol. – 2009. – Vol. 20. – P.
629-637.
107
Staples A., Le Blond R., Watkins S. et al. Validation of the revised
Schwartz estimating equation in a predominantly non-CKD population // Pediatr.
Nephrol. – 2010. – Vol. 25. – P. 2321–2326.
108
National Kidney Disease Education Program (NKDEP); GFR Calculator
for Children: Bed-side IDMS-traceable Schwartz GFR Calculator for Children.
www.nkdep.nih.gov. 25.04.2012.
109
Schwartz G.J., Work D.F. Measurement and estimation of GFR in
children and adolescents // Clin. J. Am. Soc. Nephrol. – 2009. – Vol. 4. – P.
1832
‑
1843.
110
Эрман М.В. Нефрология детского возраста: руководство для врачей /
М.В. Эрман. – Изд. 2-е. – СПб.: СпецЛит, 2010. – 683 с.
111
Stevens L.A., Levey A.S. Measured GFR as a Confirmatory Test
for Estimated GFR // J. Am. Soc. Nephrol. – 2009. – Vol. 20. – P. 2305–2313.
112
Grubb A., Nyman U., Bjork J., et al. Simple cystatin C-based prediction
equations for glomerular filtration rate compared with the modification of diet in
renal disease prediction equation for adults and the Schwartz and the Counahan-
76
Barratt prediction equations for children // Clin. Chem. – 2005. – Vol. 51. – P.
1420-1431.
113
Devarajan P. Neutrophil gelatinase-associated lipocalin: a promising
biomarker for human acute kidney injury // Biomark. Med. – 2010. – Vol. 4, №2. – Р.
265-280.
114
Geus H., Betjes M., Bakker J. Biomarkers for the prediction of acute
kidney injury: a narrative review on current status and future challenges. // Clin.
Kidney J. – 2012. – Vol. 5, №2. – P. 102-108.
115
Смирнов А.В., Добронравов В.А., Румянцев А.Ш., Шилов E.М.,
Ватазин А.В., Каюков И.Г., Кучер А.Г., Есаян А.М. Острое повреждение почек.
Основные принципы диагностики, профилактики и терапии // Нефрология. –
2016. – Т. 20, ч.1, №1. – С. 79 - 104.
116
Смирнов А.В., Каюков И.Г., Добронравов В.А., Кучер А.Г. Острое
повреждение почек – новое понятие в нефрологии. // Клиническая
нефрология. – 2009. – №1. – С. 11–15.
117
Уразаева Л.И., Максудова А.Н. Биомаркеры раннего повреждения
почек: обзор литературы // Практическая медицина. – 2014. – Т.1. – №4. – С.
125–130.
118
Ichimura T., Asseldonk E.J., Humphreys B.D. et al. Kidney injury
molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on
epithelial cells // J. Clin. Invest. - 2008. - Vol. 118. - Р.1657-1668.
119
Hiramoto J.S., Katz R., Peralta C.A. et al. Inflammation and coagulation
markers and kidney function decline: the Multi-Ethnic Study of Atherosclerosis
(MESA) // Am. J. Kidney Dis. – 2012. – Vol. 60, №2. – Р. 225-232.
120
Clerico A., Galli C., Fortunato A. et al. Neutrophil gelatinaseassociated
lipocalin (NGAL) as biomarker of acute kidney injury: a review of the laboratory
characteristics and clinical evidences // Clin. Chem. Lab. Med. – 2012. – Vol. 50,
№9. – Р. 1505-1517.
121
Harpur E., Ennulat D., Hoffman D. et al. Biological Qualification of
Biomarkers of Chemical-Induced Renal Toxicity in Two Strains of Male Rat //
Toxicol. Sci. – 2011. – Vol. 122, № 2. – Р.235-252.
122
Schiffl H., Lang S.M. Update on biomarkers of acute kidney injury:
moving closer to clinical impact? // Mol. Diagn. Ther. – 2012. – Vol. 16, № 4. – Р.
199-207.
123
Mares J., Stejskal D., Vavrauskova J. et al. Use of cystatin C determination
in clinical diagnostics // Biomed. Papers. – 2003. – Vol. 147, №2. – P. 177–180.
124
Mussap M., Plebani M. Biochemistry and clinical role of human cystatin C
// Crit. Rev. Clin. Lab. Sci. – 2004. – Vol. 41, №5. – P. 467–550.
125
Hellerstein S. The ratio of urinary cystatin C to urinary creatinine for detect
ion decreased GFR / S. Hellerstein, M. Berenbom, P. Erwin et al // Pediatr Nephrol. –
2004. – Vol. 19, №5. – P. 521–525.
126
Herget-Rosental S. Measurement of urinary cystanin C by particle
enhanced nephelometric immunoassay: precision, interference, stability and reference
77
range / S. HergetRosental, T. Feldcamp, L. Volbracht, A. Kribben // Ann. Clin.
Biochem. – 2004. – Vol. 41, №2. – P. 111–118.
127
HergetRosental S. Prognostic value of tubular proteinuria and enzymuria in
nonoliguric acute tubular necrosis / S.HergetRosental, D.Poppen, J.Husing et al //
Clin. Chem. – 2004. – Vol. 50. – P. 552–558.
128
Tkaczyk M., Nowicki M., Lukamowicz J. Increased cystatin C
concentration in urine of nephrotic children // Pediatr. Nephrol. – 2004. – Vol.
19,
№11. – P. 1278–1280.
129
Dharnidharka V.R., Kwon C., Stevens G. Serum cystatin C is superior to
serum creatinine as a marker of kidney function: a metaanalysis // Am. J. Kidney.
Dis. – 2002. – Vol. 40, №2. – P. 221–226.
130
Rodrigo E., Martin de Francisco A.L., Escallada R. et al. Measurement of
renal function in preESRD patients // Kidney Int. – 2002. – Vol. 61. – P. 11–17.
131
Takuwa S., Ito Y., Ushijima K., Uchida K. Serum cystatin C values in
children by age and their fluctuation during dehydration // Pediatr. Int. – 2002. –Vol.
44, №1. – P. 28–31.
132
Gokkusu C.A., Ozden T.A., Gul H., Yildiz A. Relationship between
plasma Cystatin C fnd creatinine in chronic renal diseases and Tx-transplant patients
// Clin. Biochem. – 2004. – Vol. 37, №2. – P. 94–97.
133
Laterza O.F., Price C.P., Scott M.G. Cystatin C: improved estimator of
glomerular filtration rate? // Clin. Chem. – 2002. – Vol. 48. – P. 669–707.
134
Черканова М.С., Короленко Т.А., Филатова Т.Г. и др.
Эндогенный
ингибитор цистеиновых протеаз цистатин С как предиктор развития
атеросклероза и изменения при операции коронарного шунтирования //
Бюллетень СО РАМН. – 2007. – Т. 125, №3. – С. 133-137.
135
Morgan С., Senthilselvan A, Bamforth F, et al.
Correlation between
cystatin С and renal scan-determined glomerular filtration rate in children with
spina bifida // Pediatr Nephrol. – 2008. – Vol. 23, №2. – P. 329-332.
136
Kristensen K., Strevens H., Lindstrom V. et al. Increased plasma levels of
beta2-microglobulin, cystatin С and beta-trace protein in term pregnancy are not
due to utero-placental production // Scand. J. Clin. Lab. Invest. – 2008. – Vol. 68,
№7. – P. 649-653.
137
Christensson A., Ekberg J., Grubb A., Ekberg H. et al. Serum cystatin С is
a more sensitive and more accurate marker of glomerular filtration rate than
enzymatic measurements of creatinine in renal transplantation // Nephron Physiol. -
2003. – Vol. 94, №2. – P. 19-27.
138
Виллевальде С.В., Гудгалис Н.И., Кобалава Ж.Д. Цистатин С как
новый маркер нарушения функции почек и сердечно-сосудистого риска
// Кардиология. – 2010. – № 6. – С. 78–82.
139
Bouvet Y., Bouissou F., Coulais Y. et al. GFR is better estimated by
considering both serum cystatin C and creatinine levels // Pediatr. Nephrol. – 2006. –
Vol. 21. – P. 1299–1306.
78
140
Короленко Т.А., Черканова М.С., Филатова Т.Г. и др. Возрастные
изменения содержания цистатина С и С-реактивного белка у здоровых лиц //
Terra medica nova. – 2007. – № 1. – 13 с.
141
Reese P., Feldman H. More Evidence that Cystatin C Predicts Mortality
Better than Creatinine // J. Am. Soc. Nephrol. – 2009. – Vol. 20. – P. 2088–2090.
142
Premaratne E., Maclsaac R.J., Finch S. et al. Serial measurements of
cystatin C are more accurate than creatinine-based methods in detecting declining
renal function in type 1 diabetes // Diabetes Care. – 2008. – Vol. 31, № 5. – P. 971–
973.
143
Резниченко Н.Е., Панфилова Е.Ю., Данкавцева Е.Н. и др.
Возможности использования цистатина в кардиологии // Медицинский
алфавит. Больница. – 2009. – № 3. – С. 23–26.
144
Цыгин А.Н., Комарова О.В., Сергеева Т.В. и др. Нефротический
синдром // Клинические рекомендации по педиатрии / под ред. Баранова
А.А. – М.: Геотар-Медиа, 2009. – C. 239–261.
145
Arpegard J., Ostergren J., de Faire U. et al. Сystatin C – marker of
peripheral atherosclerotic disease // Atherosclerosis. – 2008. – Vol. 199, №2.– P.
397–401.
146
Okura T., Jotoku M., Irita J. et al. Association between cystatin C and
inflammation in patients with essential hypertension // Clin. Exp. Nephrol. –
2010. – Vol. 31. – P. 13–17.
147
Strevens H., Wide-Swensson D., Grubb A. et al. Serum cystatin C
reflects glomerular endotheliosis in normal, hypertensive and pre-eclamptic
pregnancies // BJOG. – 2003. – Vol. 110. – P. 825–830.
148
Taglieri N., Koenig W., Kaski J.C. Cystatin C and Cardiovascular
Risk // Clin. Chem. – 2009. – Vol. 55, № 11. – P. 1932–1943.
149
Cimerman
N.,
Brgurjan
P.M.,
Krasovec M.
et al.
Serum
cystatin C, a potent inhibitor of cysteine proteinase, is elevated in asthmatic patients
// Clin. Chim. Acta. – 2000. – Vol. 300. – P. 83–95.
150
Risch L., Herklotz R., Blumberg A., Huber A.R. Effects of glucocorticoid
immunosupression on serum cystatin C concentration in renal transplant patients //
Clin. Chem. – 2001. – Vol. 47. – P. 2055–2059.
151
Watanabe S., Okura T., Liu J. et al. Serum cystatin C level is a marker of
end-organ damage in patients with essential hypertension//Hypertens. Res. – 2003. –
Vol. 26, №11. – P. 895–899.
152
Stabuc B., Vrhovec L., Stabuc-Silin M., Cizey T.E. Improved prediction
of decreased creatinine clearance by serum cystatin C: Use in cancer patients before
and during chemotherapy // Clin. Chem. – 2000. – Vol. 46, №2. – P. 193–197.
153
Piepsz
A.,
Tondeur
M.,
Ham
H.
Revisiting
normal
(51)
Crethylenediaminetetraacetic acid clearance values in children // Eur. J. Nucl. Med.
Mol. Imaging. – 2006. – Vol. 33, № 12. – P. 1477-1482.
154
Harmoinen A., Ylinen E., la-Houhala M et al. Reference intervals for
cystatin C in pre-and full-term infants and children // Pediatr. Nephrol. – 2000. – Vol.
15. – P. 105–108.
79
155
Novo A.C., Sadeck Ldos S., Okay T.S. et al. Longitudinal study of
Cystatin C in healthy term newborns // Clinics. – 2011. – Vol. 66. – P. 217-220.
156
Kellum J.A, Levin N., Bouman C., Lameire N. Developing a consensus
classifi cation system for acute renal failure // Curr Opin Crit Care. – 2002. –Vol. 8. –
Р. 509–514.
157
Herget-Rosental S., Marggraf G., Husing J. et al. Early detection of acute
renal failure by serum cystatin C // Kidney Int. – 2004. – Vol. 66, №3. – P. 1115–
1122.
158
Endre z.H., Pickering J.W., Walker R.J. et al. Improved performance of
urinary biomarkers of acute kidney injury in the critically ill by stratification for injury
duration and baseline renal function // Kidney Int. – 2011. – Vol. 79, №10. – P.
1119–1130.
159
Bell M., Granath F., Martensson J. et al. Cystatin C is correlated
with
mortality in patients with and without acute kidney injury // Nephrol. Dial. Transplan.
– 2009. – Vol. 24, №10. – P. 3096–3102.
160
Chung M.Y., Jun D.W., Sung S.A. Diagnostic value of cystatin C for
predicting acute kidney injury in patients with liver cirrhosis
// Korean J. Hepatol. –
2010. – Vol. 16, №3. – P. 301–307.
161
Dai X., Zeng Z., Fu C., Zhang S., Cai Y., Chen Z. Diagnostic value of
neutrophil gelatinaseassociated lipocalin, cystatin C, and soluble triggering receptor
expressed on myeloid cells1 in critically ill patients with sepsisassociated acute kidney
injury // Crit. Care. – 2015. – Vol. 6. – P. 19–223.
162
Yim H., Kym D., Seo D.K. et. al. Serum cystatin C and microalbuminuria
in burn patients with acute kidney injury // Eur. J. Clin. Invest. – 2015. – Vol. 45, №6.
– P. 594–600.
163
Zappitelli M., Greenberg J.H., Coca S.G. et. al. Parikh Translational
Research Investigating Biomarker Endpoints in Acute Kidney Injury (TRIBE
АKI)
Consortium. Association of definition of acute kidney injury by cystatin C rise with
biomarkers and clinical outcomes in children undergoing cardiac surgery //
JAMA Pediatr. – 2015. – Vol. 169, №6. – P. 583–591.
164
Herget-Rosenthal S., Marggraf G., Husing J. et al. Early detection of acute
renal failure by serum cystatin C // Kidney Int. – 2004. – Vol. 66. – Р. 1115–1122.
165
Смирнов А.В., Добронравов В.А., Каюков И.Г.
Кардиоренальный
континуум: патогенетические основы превентивной нефрологии // Нефрология –
2005. – T. 9, №3. – P. 7–15.
166
McCullough P.A. Cardiorenal syndromes: Pathophysiology to prevention
// Int. J. Nephrol. – 2011. – P. 762–590.
167
Ronco C., McCullough P., Anker S.D., Anand I. et. al. Cardiorenal
syndromes: report from the consensus conference of the acute dialysis
quality initiative // Eur. Heart. J. – 2010. – Vol. 31, №6. – P. 703–711.
168
Смирнов А.В., Седов В.М., Од-Эрдэнэ Лхаахуу., Каюков И.Г. и др.
Снижение скорости клубочковой фильтрации как независимый фактор риска
сердечно-сосудистой болезни // Нефрология. – 2006. – T.10, №4. – С. 7–17.
80
169
Henry R.M., Kostense P.J., Bos G. et al. Mild renal insufficiency is
associated with increased cardiovascular mortality: the Hoorn Study // Kidney Int. –
2002. – Vol. 62. – P. 1402–1407.
170
Majunath G., Tighionart H., Ibrahim H. et. al. Level of kidney function
as a risk factors for atherosclerotic cardiovascular outcomes in the community //
J. Am. Coll. Cardiol. – 2003. – Vol. 41. – P. 47– 55.
171
Vanholder R., Massy Z., Argiles A.
et al. Chronic kidney disease as cause
of cardiovascular morbidity and mortality // Nephrol. Dial. Transplant. – 2005. –
Vol. 20, №6. – P. 1048–1056.
172
Lassus J., Harjola V.P. Cystatin C: a step forward in assessing kidney
function and cardiovascular risk // Heart Fail. Rev. – 2012. – Vol. 17, № 2. – P. 251–
61.
173
Dzielinska Z., Januszewicz A., Wiecek A. et al. Reduced kidney function
estimated by cystatin C and clinical outcomes in hypertensive patients with coronary
artery disease: association with homocysteine and other cardiovascular risk factors //
Kidney Blood Press. Res. – 2010. – Vol. 33, №2. – P. 139-148.
174
Hoke M., Amighi J., Mlekusch W. et al. Cystatin C and the risk for
cardiovascular events in patients with asymptomatic carotid atherosclerosis // Stroke.
– 2010. – Vol. 41, № 4. – P. 674-679.
175
Rifkin D.E., Katz R., Chonchol M., Fried L.F. et al. Albuminuria,
impaired kidney function and cardiovascular outcomes or mortality in the elderly //
Nephrol. Dial. Transplant. – 2010. – Vol. 25, №5. – P. 1560-1567.
176
Ge C., Ren F., Lu S., Ji F., Chen X., Wu X. Clinical prognostic
significance of plasma cystatin C levels among patients with acute coronary
syndrome // Clin. Cardiol. – 2009. – Vol. 32, №11. – P. 644-648.
177
Shlipak M.G., Katz R., Kestenbaum B. et al. Rapid decline of kidney
function increases cardiovascular risk in the elderly // J. Am. Soc. Nephrol. – 2009. –
Vol. 20, № 12. – P. 2625-2630.
178
Beilby J., Divitini M.L., Knuiman M.W. et al. Comparison of cystatin C
and creatinine as predictors of cardiovascular events in a community-based elderly
population // Clin. Chem. – 2010. – Vol. 56, № 5. – P. 799-804.
179
Сенаторова А.С., Муратова Е.Г. Диагностическая ценность
цистатина C в моче у детей с сахарным диабетом 1-го типа как раннего маркѐра
диабетической нефропатии // Казанский медицинский журнал. – 2013. – № 2. –
P. 186-218.
180
Pucci L., Triscornia S., Lucchesi D. et al. Cystatin C and estimates of
renal function: searching for a better measure of kidney function in diabetic patients //
Clin. Chem. – 2007. – Vol. 53. – P. 480–488.
181
Rigalleau V., Beauvieux M.C., Le Moigne F. et al. Cystatin C improves
the diagnosis and stratification of chronic kidney disease, and the estimation of
glomerular filtration rate in diabetes // Diabetes. Metab. – 2008. – Vol. 34. – P. 482–
489.
182
El-Shafey E.M., El-Nagar G.F., Selim M.F. et al. Is serum cystatin C an
accurate endogenous marker of glomerular filteration rate for detection of early renal
81
impairment in patients with type 2 diabetes mellitus? // Ren. Fail. – 2009. – Vol. 31,
№ 5. – P. 355-359.
183
Chudleigh R.A., Ollerton R.L., Dunseath G. et al. Use of cystatin C-based
estimations of glomerular filtration rate in patients with type 2 diabetes //
Diabetologia. – 2009. – Vol. 52, № 7. – P. 1274-1278.
184
Perkins B.A., Nelson R.G., Ostrander B.E. et al. Detection of renal
function decline in patients with diabetes and normal or elevated GFR by serial
measurements of serum cystatin C concentration: results of a 4-year follow-up study
// J. Am. Soc. Nephrol. – 2005. – Vol. 16, № 5. – P. 1404–1412.
185
Li H.X., Xu G.B., Wang X.J., Zhang X.C., Yang J.M. Diagnostic
accuracy of various glomerular filtration rates estimating equations in patients with
chronic kidney disease and diabetes // Chin. Med. J. – 2010. – Vol. 123, № 6. – P.
745-751.
186
Jeon Y.K., Kim M.R., Huh J.E. et al. Cystatin C as an early biomarker of
nephropathy in patients with type 2 diabetes // J. Korean. Med. Sci. – 2011. – Vol. 26,
№ 2. – P. 258-263.
187
Borges R.L., Hirota A.H., Quinto B.M. et al. Is cystatin C a useful marker
in the detection of diabetic kidney disease?/ R.L.Borges, //Nephron Clin Pract. –
2010. – Vol.2, №114. – P. 127-134.
188
Haase M., Kellum J.A., Ronco C. Subclinical AKI - an emerging
syndrome with important consequences // Nat. Rev. Nephrol. – 2012. – Vol.8, № 12.
– P. 735-739.
189
Peacock W.F., Maisel A., Kim J., Ronco C. Neutrophil gelatinase
associated lipocalin in acute kidney injury // Postgrad. Med. – 2013. – Vol. 125, № 6.
– P. 82-93.
190
Hjortrup P.B., Haase N., Wetterslev M., Perner A. Clinical review:
Predictive value of neutrophil gelatinase-associated lipocalin for acute kidney injury
in intensive care patients // Crit. Care. – 2013. – Vol. 17, № 2. – 211 р.
191
Antonucci E.1., Lippi G., Ticinesi A. et al. Neutrophil gelatinase-
associated lipocalin (NGAL): a promising biomarker for the early diagnosis of acute
kidney injury (AKI) // Ata. Biomed. – 2014. – Vol. 85, № 3. – P. 289-294.
192
Haase-Fielitz A., Haase M., Devarajan P. Neutrophil gelatinase-associated
lipocalin as a biomarker of acute kidney injury: a critical evaluation of current status
// Ann. Clin. Biochem. – 2014. – Vol. 51. – P. 335-351.
193
Martensson J.1., Bellomo R. The rise and fall of NGAL in acute kidney
injury // Blood. Purif. – 2014. – Vol. 37, № 4. – P. 304-310.
194
Haase M., Devarajan P., Haase-Fielitz A., Bellomo R., Cruz D.N. et. al.
The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute
kidney injury: a multicenter pooled analysis of prospective studies // J. Am. Coll.
Cardiol. – 2011. – Vol. 26, № 57. – P. 1752-1761.
195
Ronco C., Kellum J.A., Haase M. Subclinical AKI is still AKI // Crit.
Care. – 2012. – Vol. 16, № 3. – 313 р.
82
196
Wasilewska A., Zoch-Zwierz W., Taranta-Janusz K. et al. Neutrophil
gelatinase–associated lipocalin (NGAL): a new marker of cyclosporine
nephrotoxicity // Pediatr. Nephrol. – 2010. – Vol. 25, № 5. – P. 889-897.
197
Bachorzewska-Gajewska H., Malyszko J., Sitniewska E. et al. Could
neutrophil gelatinase–associated lipocalin and cystatin C predict the development of
contrast-induced nephropathy after percutaneous coronary interventions in patients
with stable angina and normal serum creatinine values // Kidney Blood. Press. Res.
– 2007. – Vol. 30, № 6. – P. 408–415.
198
Bachorzewska-Gajewska H., Malyszko J., Sitniewska E. et al. Neutrophil
gelatinase–associated lipocalin and renal function after percutaneous coronary
interventions // Clin. J. Am. Soc. Nephrol. – 2006. – Vol. 26. – P. 287–292.
199
Cruz D.N., de Cal М., Garzotto F. Plasma neitrophil gelatinase-associated
lipocalin is an early biomarker for acute kidney injury in an adult ICU population //
Intensive Care Med. – 2010. – Vol. 36. – P. 444-451.
200
Haase-Fielitz, A., Bellomo R., Devarajan P. Novel and conventional
serum biomarkers predicting acute kidney injury in adult cardiac surgery: a
prospective cohort study // Crit. Care Med. – 2009. – Vol. 37. – P. 553-560.
201
Kumpers P., Hafer C., Lukasz A.
et al. Serum neitrophil gelatinase-
associated lipocalin at inception of renal replacement therapy predicts survival in
critically ill patients with acute kidney injury // Crit. Care. – 2010. – Vol. 14. – 9 р.
202
Bennett M.R., Dent C.L. et al. Urine NGAL predicts severity of acute
kidney injury after cardiac surgery: a prospective study // Clin. J. Am. Soc. Nephrol.
– 2008. – Vol. 3, № 3. – P. 665–673.
203
Trachtman H., Christen E., Cnaan A. et al. Urinary neutrophil gelatinase–
associated lipocalin in D+HUS: a novel marker of renal injury // Pediatr. Nephrol. –
2006. – № 21. – P. 989–994.
204
Zhang Z.1., Lu B., Sheng X., Jin N. Cystatin C in prediction of acute
kidney injury: a systemic review and meta-analysis // Am. J. Kidney. Dis. – 2011. –
Vol. 58, № 3. – P. 356-365.
205
Weinert L.S., Camargo E.G., Soares A.A., Silveiro S.P. Glomerular
filtration rate estimation: performance of serum cystatin C-based prediction equations
// Clin. Chem. Lab. Med. – 2011. – Vol. 49, № 11. – P. 1761-1771.
206
Shlipak M.G., Matsushita K., Arnlov J. et. al. CKD Prognosis
Consortium. Cystatin C versus creatinine in determining risk based on kidney
function // N. Engl. J. Med. – 2013. – Vol. 369, № 10. – P. 932-943.
207
Haase M., Bellomo R., Devarajan P. et al. Accuracy of Neutrophil
Gelatinase-Associated Lipocalin (NGAL) in Diagnosis and Prognosis in Acute
Kidney Injury: A Systematic Review and Meta-analysis // Am. J. Kidney. Dis. –
2009. – Vol. 54, № 6. – P. 1012-1024.
208
Cagemi G., Storti S., Cantinotti M.
et. al. Reference Values for Urinary
Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Pediatric Age Measured with
a Full Automated Chemiluminescent Platform // Clin. Chem. Lab. Med. – 2013. –
№ 51. – P. 1101-1105.
83
209
Cullen M.R., Murray P.T., Fitzgibbon M.C.
et. al. Establishment of a
Reference Interval for Urinary Neutrophil Gelatinase-Associated Lipocalin // Annals
of Clinical Biochemistry. – 2012. – № 49. – P. 190-193.
210
Finney H., Newman D.J., Thakkar H. et al. Reference ranges for plasma
cystatin C and creatinine measurements in premature infants, neonates, and older
children // Arch. Dis. Child. – 2000. – Vol. 82, № 1. – Р. 71–75.
211
Ceriotti F., Boyd J.C., Klein G.
et al. Reference intervals for serum
creatinine concentrations: assessment of available data for global application //
Clin. Chem. – 2008. – Vol. 54. – P. 559-566.
212
Wuyts B., Bernard D., Van den Noortgate N.
et. al. Reevaluation of
formulas for predicting creatinine clearance in adults and children, using
compensated creatinine methods // Clin. Chem. – 2003. – Vol. 49. – P. 1011-1014.
213
Ognibene A., Mannucci E., Caldini A. et al.
Cystatin С reference values
and aging // Clin. Biochem. – 2006. – Vol. 39, № 6. – P. 658-661.
214
Novo A.C., Sadeck L.D.S., Okay T.S. et. al. Longitudinal study of
cystatin С in healthy term newborns // Clinics (Sao Paulo). – 2011. – Vol. 66, № 2. –
P. 217-220.
215
ДаминоваМ.А., СафинаА.И. Прогностическое значение определения
уровня липокалина-2, ассоциированного с нейтрофильной желатиназой (NGAL)
в моче у новорожденных в критических состояниях // Практическая медицина.
– 2012. – Vol. 7, № 1. – 35 с.
216
Yilmaz A., Sevketoglu E., Gedikbasi A. et al. Early prediction of urinary
tract infection with urinary neutrophil gelatinase associated lipocalin // Pediatr.
Nephrol. – 2009. – Vol. 24, № 12. – P. 2387–2392.
217
World Health Organization. The treatment of diarrhea: a manual for
physicians and other senior health workers, 4th rev. ed. Geneva: World Health
Organization, 2005.
218
Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney
Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury //
Kidney inter. – 2012. – Suppl. 2. – Р. 1-138. www.kidney-international.org.
219
Учайкин В.Ф., Новокшонов A.A., Чуелов С.Б. и др. Этиологическая
структура острых кишечных инфекций у детей в г. Москве // Материалы VIII
конгресса детских инфекционистов России. – М., 2009. – 138 с.
220
Милютина Л.Н., Гурьева О.В. Возрастные аспекты эволюции
современного сальмонеллеза у детей // Материалы VIII конгресса детских
инфекционистов России. – М., 2009. – С. 86-87.
221
Амирова Д.М. Состояние неспецифической резистентности и
цитокинового статуса у больных острой бактериальной дизентерией,
совершенствование терапии: автореф.
… докт. мед. наук: 14.01.09. – Москва,
2010. – 25 с. – Инв. № 004610418.
222
Инфекционная заболеваемость за январь-декабрь 2007 г. в
Российской Федерации // Детские инфекции. – 2008. – Т. 7, № 1. – 3 с.
223
Вовк Т.Г., Кузнецов C.B., Татаркина А.Н. и др. Роль
иммунологических показателей при обосновании терапии детей, больных
84
эшерихиозом: материалы VIII конгресса детских инфекционистов России. –
М., 2009. – 28 с.
224
Дубровская Д.Н., Мурзабаева Р.Т., Валишин Д.А. Сравнительная
характеристика течения острых кишечных инфекций у взрослых, вызываемых
условно-патогенной флорой // Материалы I Ежегодного Всероссийского
Конгресса по инфекционным болезням. – М., 2009. – С. 61–62.
225
Сбойчаков В.Б., Захаренко С.М., Финогеев Ю.П., Крумгольц В.Ф.
Эпидемиология, клиника и лабораторная диагностика бактериальных и
вирусных диарей // Лечение и профилактика. – 2012. – № 3 (4). – С. 77-81.
226
Завгородняя Е.Ф., Сташкевич Л.А. Некоторые биологические
свойства
условно-патогенных
бактерий
в
структуре
кишечных
микробиоценозов у детей с нарушениями кишечной микроэкологии //
Клиническое питание. – 2007. – № 1-2. – 42 с.
227
Boirivant M., Amendola A., Butera A. Intestinal microflora and
immunoregulation // Mucosal. Immunol. – 2008. – № 1. – P. 47-49.
228
Халиуллина С.В., Анохин В.А., Николаева И.В., Валиахметова Л.Х.
Особенности острых кишечных инфекций, протекающих с синдромом
обезвоживания // Практическая медицина. – 2013. – Т. 75, № 6. – С. 133-140.
Достарыңызбен бөлісу: |